Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06144632 · ClinicalTrials.gov registry record · NA
A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAF
A NA study, sponsored by Biosense Webster.
- Completed
- Registry status
- NA
- Development phase
- 237
- Enrollment target
NCT06144632 is a NA study that has completed, run by Biosense Webster. The registered enrollment target is 237 participants.
The verdict
NCT06144632, a NA study, has completed, sponsored by Biosense Webster.
- COMPLETED
- Registry status
- NA
- Development phase
- 237 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate safety and effectiveness of the Biosense Webster (BWI) ablation system (THERMOCOOL SMARTTOUCH surround flow \[STSF\] catheter and TRUPULSE generator) when used for isolation of the atrial pulmonary veins (PVs) in treatment of participants with paroxysmal atrial fibrillation (PAF), an irregular heart rate that causing abnormal blood flow.
Interventions
- DEVICE THERMOCOOL STSF Bi- Directional Navigation Catheter
- DEVICE TRUPULSE Generator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 237 participants |
| Start Date | 2023-12-07 |
| Est. Completion | 2025-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06144632
The ClinicalTrials.gov registry entry for NCT06144632 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 237 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biosense Webster, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which THERMOCOOL STSF Bi- Directional Navigation Catheter is the first listed.
NCT06144632 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06144632 about?
NCT06144632 is a clinical study titled "A Study of the THERMOCOOL SMARTTOUCH Surround Flow (SF) Catheter With the TRUPULSE Generator for Treatment of Drug Refractory Symptomatic PAF". The purpose of this study is to demonstrate safety and effectiveness of the Biosense Webster (BWI) ablation system (THERMOCOOL SMARTTOUCH surround flow \[STSF\] catheter and TRUPULSE generator) when used for isolation of the atrial pulmonary veins (PVs) in treatment of participants with paroxysmal a...
What is the current status of trial NCT06144632?
This trial is currently completed. It is a NA study. The enrollment target is 237 participants. The study started on 2023-12-07. Estimated completion is 2025-10-30.
What interventions are being tested in trial NCT06144632?
The interventions under investigation include: THERMOCOOL STSF Bi- Directional Navigation Catheter (DEVICE), TRUPULSE Generator (DEVICE).
Who is sponsoring clinical trial NCT06144632?
This trial is sponsored by Biosense Webster, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.